David H. Johnson

Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

Jenny C. Taylor, Hilary C. Martin, Stefano Lise et al. · Nature Genetics · 2015 · 388 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results

A. Y. Chang, K. Kim, John H. Glick et al. · JNCI Journal of the National Cancer Institute · 1993 · 339 citations

Medicine, Oncology, Pharmacology +12

Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial

Rodger D. MacArthur, Mark Miller, Timothy Albertson et al. · Clinical Infectious Diseases · 2004 · 273 citations

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +16

His-tag impact on structure

Mike Carson, David H. Johnson, Heather M. McDonald et al. · Acta Crystallographica Section D Biological Crystallography · 2007 · 237 citations

Life Sciences, Biochemistry, Biophysics +15

Chronic daily administration of oral etoposide--a phase I trial.

John D. Hainsworth, David H. Johnson, Sheryl Redlin Frazier et al. · Journal of Clinical Oncology · 1989 · 150 citations

Medicine, Oncology, Pharmacology +15